CoChat
Sign Up
Cited by 3

The influence of environmental risk factors in the development of ALS in the Mediterranean Island of Cyprus

Mitsi, Ellie, Christodoulou, Christiana C., Nicolaou, Paschalis, Christodoulou, Kyproula, Zamba-Papanicolaou, Eleni·2023·Frontiers in Neurology
DOI 10.3389/fneur.2023.1264743PMC PMC10701549
Open this paper in CoChat — free account

Abstract

Introduction: Amyotrophic lateral sclerosis (ALS) is a devastating, uniformly lethal degenerative disease of motor neurons, presenting with relentlessly progressive muscle atrophy and weakness. The etiology of ALS remains unexplained for over 85% of all cases, suggesting that besides the genetic basis of the disease, various environmental factors are implicated in the pathogenesis of ALS. This study aimed to investigate the contribution of known environmental risk factors of ALS in the Cypriot population. Methods: We conducted a case–control study with a total of 56 ALS cases and 56 healthy gender/age-matched controls of Cypriot nationality. Demographic, lifestyle characteristics, medical conditions, and environmental exposures were collected through the use of a detailed questionnaire. Statistical analyses using the R programming language examined the association between the above environmental factors and ALS. Results: A chi-square test analysis revealed a statistically significant (p = 0.000461) difference in smoking status between the two groups. In addition, univariate logistic regression analysis showed a statistically significant association between ALS cases for head trauma/injury (p = 0.0398) and exposure to chemicals (p = 0.00128), compared to controls. Conclusion: This case–control investigation has shed some light on the epidemiological data of ALS in Cyprus, by identifying environmental determinants of ALS, such as smoking, head trauma, and chemical exposure, in the Cypriot population.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fneur.2023.1264743

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 36

  1. [1]Turner MR Swash M Ebers GC. Lockhart Clarke’s contribution to the description of amyotrophic lateral sclerosis. Brain. (2010) 133: 3470– 9. doi: 10.1093/brain/awq097, PMID: 20576696 PMC3182545 · DOI
  2. [2]Longinetti E Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. (2019) 32: 771– 6. doi: 10.1097/WCO.0000000000000730, PMID: 31361627 PMC6735526 · DOI · Paper page
  3. [3]Arthur KC Calvo A Price TR Geiger JT Chiò A Traynor BJ. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat Commun. (2016) 7: 1– 6. doi: 10.1038/ncomms12408 PMC4987527 27510634 · DOI
  4. [4]Xu L Liu T Liu L Yao X Chen L Fan D. Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol. (2020) 267: 944– 53. doi: 10.1007/s00415-019-09652-y, PMID: 31797084 · DOI
  5. [5]Logroscino G Traynor BJ Hardiman O Chio A Mitchell D Swingler RJ. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. (2010) 81: 385– 90. doi: 10.1136/jnnp.2009.183525, PMID: 19710046 PMC2850819 · DOI · Paper page
  6. [6]GBD 2016 Motor Neuron Disease Collaborators. Global, regional, and national burden of motor neuron diseases 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. (2018) 17: 1083– 97. doi: 10.1016/S1474-4422(18)30404-6, PMID: 30409709 PMC6234315 · DOI
  7. [7]Zhou S Zhou Y Qian S Chang W Wang L Fan D. Amyotrophic lateral sclerosis in Beijing: epidemiologic features and prognosis from 2010 to 2015. Brain Behav. (2018) 8: 1– 7. doi: 10.1002/brb3.1131 PMC6236245 30338660 · DOI
  8. [8]Leighton DJ Newton J Stephenson LJ Colville S Davenport R Gorrie G. Changing epidemiology of motor neurone disease in Scotland. J Neurol. (2019) 266: 817– 25. doi: 10.1007/s00415-019-09190-7, PMID: 30805795 · DOI
  9. [9]Palese F Sartori A Verriello L Ros S Passadore P Manganotti P. Epidemiology of amyotrophic lateral sclerosis in Friuli-Venezia Giulia, north-eastern Italy, 2002–2014: a retrospective population-based study. Amyotroph Lateral Scler Front Degener. (2019) 20: 90– 9. doi: 10.1080/21678421.2018.1511732, PMID: 30430867 · DOI
  10. [10]Mejzini R Flynn LL Pitout IL Fletcher S Wilton SD Akkari PA. ALS genetics, mechanisms, and therapeutics: where are we now? Front Neurosci. (2019) 13: 1– 27. doi: 10.3389/fnins.2019.01310 31866818 PMC6909825 · DOI
  11. [11]Ingre C Roos PM Piehl F Kamel F Fang F. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. (2015) 7: 181– 93. doi: 10.2147/CLEP.S37505, PMID: 25709501 PMC4334292 · DOI
  12. [12]Filippini T Fiore M Tesauro M Malagoli C Consonni M Violi F. Clinical and lifestyle factors and risk of amyotrophic lateral sclerosis: a population-based case-control study. Int J Environ Res Public Health. (2020) 17: 1– 17. doi: 10.3390/ijerph17030857 PMC7037077 32019087 · DOI · Paper page
  13. [13]BhattV KC Behal M. Risk factors of amyotrophic lateral sclerosis (ALS): an updated systematic review. URNCST J. (2022) 6: 1– 11. doi: 10.26685/urncst.348, PMID: 37316187 · DOI
  14. [15]Vasta R Chia R Traynor BJ Chiò A. Unraveling the complex interplay between genes, environment, and climate in ALS. EBioMedicine. (2022) 75: 103795. doi: 10.1016/j.ebiom.2021.103795, PMID: 34974309 PMC8728044 · DOI
  15. [16]Zhu Q Zhou J Zhang Y Huang H Han J Cao B. Risk factors associated with amyotrophic lateral sclerosis based on the observational study: a systematic review and meta-analysis. Front Neurosci. (2023) 17: 1196722. doi: 10.3389/fnins.2023.1196722, PMID: 37284659 PMC10239956 · DOI
  16. [17]Lian L Liu M Cui L Guan Y Liu T Cui B. Environmental risk factors and amyotrophic lateral sclerosis (ALS): a case-control study of ALS in China. J Clin Neurosci. (2019) 66: 12– 8. doi: 10.1016/j.jocn.2019.05.036 31155341 · DOI
  17. [18]Sutedja NA Veldink JH Fischer K Kromhout H Heederik D Huisman MHB. Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: a systematic review. Amyotroph Lateral Scler. (2009) 10: 302– 9. doi: 10.3109/17482960802455416, PMID: 19922117 · DOI
  18. [19]Zhang L Tang L Huang T Fan D. Association between type 2 diabetes and amyotrophic lateral sclerosis. Sci Rep. (2022) 12: 2544– 7. doi: 10.1038/s41598-022-06463-6, PMID: 35169211 PMC8847454 · DOI
  19. [20]Yu Y Su FC Callaghan BC Goutman SA Batterman SA Feldman EL. Environmental risk factors and amyotrophic lateral sclerosis (ALS): a case-control study of ALS in Michigan. PLoS One. (2014) 9: 1– 9. doi: 10.1371/journal.pone.0101186 PMC4076303 24979055 · DOI
  20. [21]Wang MD Little J Gomes J Cashman NR Krewski D. Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis. Neurotoxicology. (2017) 61: 101– 30. doi: 10.1016/j.neuro.2016.06.015, PMID: 27377857 · DOI · Paper page
  21. [22]Malek AM Barchowsky A Bowser R Heiman-Patterson T Lacomis D Rana S. Environmental and occupational risk factors for amyotrophic lateral sclerosis: a case-control study. Neurodegener Dis. (2014) 14: 31– 8. doi: 10.1159/000355344, PMID: 24246552 · DOI
  22. [23]Zhang L Tang L Xia K Huang T Fan D. Education, intelligence, and amyotrophic lateral sclerosis: a mendelian randomization study. Ann Clin Transl Neurol. (2020) 7: 1642– 7. doi: 10.1002/acn3.51156, PMID: 32810387 PMC7480912 · DOI
  23. [24]Iu G Ou S Cui H Li X Yin Z Gu D. Head injury and amyotrophic lateral sclerosis: a meta-analysis. Neuroepidemiology. (2021) 55: 11– 9. doi: 10.1159/000510987 33621971 · DOI · Paper page
  24. [26]Pupillo E Messina P Giussani G Logroscino G Zoccolella S Chiò A. Physical activity and amyotrophic lateral sclerosis: a European population-based case-control study. Ann Neurol. (2014) 75: 708– 16. doi: 10.1002/ana.24150, PMID: 24706338 · DOI · Paper page
  25. [27]Peter RS Rosenbohm A Dupuis L Brehme T Kassubek J Rothenbacher D. Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia. Eur J Epidemiol. (2017) 32: 901– 8. doi: 10.1007/s10654-017-0318-z, PMID: 28975435 · DOI · Paper page
  26. [28]Nakken O Meyer HE Stigum H Holmøy T. High BMI is associated with low ALS risk: a population-based study. Neurology. (2019) 93: E424– 32. doi: 10.1212/WNL.0000000000007861, PMID: 31243073 · DOI · Paper page
  27. [29]Jha P. The hazards of smoking and the benefits of cessation: a critical summation of the epidemiological evidence in high-income countries. elife. (2020) 9: e49979. doi: 10.7554/eLife.49979, PMID: 32207405 PMC7093109 · DOI
  28. [30]Ma C Liu Y Neumann S Gao X. Nicotine from cigarette smoking and diet and Parkinson disease: a review. Transl Neurodegener. (2017) 6: 18. doi: 10.1186/s40035-017-0090-8, PMID: 28680589 PMC5494127 · DOI
  29. [31]Alonso A Logroscino G Jick SS Hernán MA. Association of smoking with amyotrophic lateral sclerosis risk and survival in men and women: a prospective study. BMC Neurol. (2010) 10: 6. doi: 10.1186/1471-2377-10-6, PMID: 20074360 PMC2820482 · DOI
  30. [32]De Jong SW Huisman MHB Sutedja NA Van Der Kooi AJ De Visser M Schelhaas HJ. Smoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: a population-based study. Am J Epidemiol. (2012) 176: 233– 9. doi: 10.1093/aje/kws015, PMID: 22791740 · DOI
  31. [34]Demetriou CA Hadjivasiliou M Kleopa KA. Epidemiology of Amyotrophic Lateral Sclerosis in the Republic of Cyprus: A 25-Year Retrospective Study. Neuroepidemiology. (2017) 48: 79– 85. doi: 10.1159/000477126 28528330 · DOI
  32. [35]Weisskopf MG McCullough ML Calle EE Thun MJ Cudkowicz M Ascherio A. Prospective study of cigarette smoking and amyotrophic lateral sclerosis. Am J Epidemiol. (2004) 160: 26– 33. doi: 10.1093/aje/kwh179, PMID: 15229114 · DOI · Paper page
  33. [36]Weisskopf MG Morozova N O’Reilly EJ McCullough ML Calle EE Thun MJ. Prospective study of chemical exposures and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. (2009) 80: 558– 61. doi: 10.1136/jnnp.2008.156976, PMID: 19372290 PMC2765376 · DOI
  34. [37]Gallagher JP Talbert OR. Motor neuron syndrome after electric shock. Acta Neurol Scand. (1991) 83: 79– 82. doi: 10.1111/j.1600-0404.1991.tb04653.x, PMID: 2017901 · DOI
  35. [39]Abhinav K Al-Chalabi A Hortobagyi T Leigh PN. Electrical injury and amyotrophic lateral sclerosis: a systematic review of the literature. J Neurol Neurosurg Psychiatry. (2007) 78: 450– 3. doi: 10.1136/jnnp.2006.104414, PMID: 17098839 PMC2117843 · DOI
  36. [40]Morahan JM Pamphlett R. Amyotrophic lateral sclerosis and exposure to environmental toxins: an Australian case-control study. Neuroepidemiology. (2006) 27: 130– 5. doi: 10.1159/000095552, PMID: 16946624 · DOI

Cited by

Sorted by citations

Authors
Mitsi, E., Christodoulou, C. C., Nicolaou, P., Christodoulou, K., & Zamba-Papanicolaou, E.
Venue
Frontiers in Neurology
Publisher
Frontiers Media SA
Published
2023-11-23
Volume
14
ISSN
1664-2295
DOI
10.3389/fneur.2023.1264743
PMC
PMC10701549
Cited by
3
References
4
Licence
creativecommons.org/licenses/by/4.0/ (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review